Quantitative Investment Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.34M Buy
14,305
+6,157
+76% +$947K 0.24% 117
2025
Q4
$1.42M Buy
+8,148
New +$1.49M 0.14% 154
2025
Q3
Sell
-12,615
Closed -$1.27M 416
2025
Q2
$1.27M Buy
+12,615
New +$965K 0.17% 119
2021
Q1
Sell
-9,206
Closed -$306K 582
2020
Q4
$306K Sell
9,206
-28,264
-75% -$1.03M 0.02% 398
2020
Q3
$1.2M Buy
+37,470
New +$1.08M 0.1% 168
2020
Q2
Sell
-41,619
Closed -$667K 590
2020
Q1
$667K Buy
+41,619
New +$987K 0.07% 272
2019
Q2
Sell
-14,500
Closed -$421K 719
2019
Q1
$421K Buy
+14,500
New +$376K 0.02% 523
2018
Q3
Sell
-18,600
Closed -$439K 746
2018
Q2
$439K Buy
+18,600
New +$479K 0.01% 620

Other funds holding INSM

Quantitative Investment Management's INSM Position: Q1 2026 in Review

Quantitative Investment Management increased its Insmed (INSM) stake by 76% in Q1 2026, buying an estimated $947K and bringing the position to 14,305 shares worth $2.34M. The position accounts for 0.24% of the portfolio, ranked #117.

Quantitative Investment Management first reported a position in INSM in Q2 2018 and has held it in 8 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Quantitative Investment Management held 14,305 shares of Insmed worth $2.34M as of Q1 2026.
  • Quantitative Investment Management bought 6,157 Insmed shares in Q1 2026, an estimated $947K.
  • Insmed made up 0.24% of Quantitative Investment Management's portfolio in Q1 2026, its #117 holding.
  • Quantitative Investment Management first reported a position in Insmed in Q2 2018 and has held it in 8 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.